Peter J. Gruber

Peter J. Gruber

Auto-generated profile, based on publicly available information

Peter J. Gruber

Division of Cardiac Surgery, Department of Surgery, Yale School of Medicine, New Haven, Connecticut, USA

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 August 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
RYRan Yang
Ran Yang
AGAlexander Goedel
Alexander Goedel
YKYu Kang
Yu Kang
CSChenyang Si
Chenyang Si
CCChu Chu
Chu Chu
KCKenneth R. Chien
Kenneth R. Chien
Embryonic development is largely conserved among mammals. However, certain genes show divergent functions. By generating a transcriptional atlas containing >30,000 cells from post-implantation non-human primate embryos, we uncover that ISL1, a gene with a well-established role in cardiogenesis, controls a gene regulatory network in primate amnion. CRISPR/Cas9-targeting of ISL1 results in non-human primate embryos which do not yield viable offspring, demonstrating that ISL1 is critically required in primate embryogenesis. On a cellular level, mutant ISL1 embryos display a failure in mesoderm formation due to reduced BMP4 signaling from the amnion. Via loss of function and rescue studies in human embryonic stem cells we confirm a similar role of ISL1 in human in vitro derived amnion. This study highlights the importance of the amnion as a signaling center during primate mesoderm formation and demonstrates the potential of in vitro primate model systems to dissect the genetics of early human embryonic development.

26 October 2021 in Circulation
Verified
Journal Article
Open access
PDF file
Markus KraneMarkus Krane
Markus Krane
MDMartina Dreßen
Martina Dreßen
GSGianluca Santamaria
Gianluca Santamaria
IMIlaria My
Ilaria My
CSChristine M. Schneider
Christine M. Schneider
AMAlessandra Moretti
Alessandra Moretti
Background: Complex molecular programs in specific cell lineages govern human heart development. Hypoplastic left heart syndrome (HLHS) is the most common and severe manifestation within the spectrum of left ventricular outflow tract obstruction defects occurring in association with ventricular hypoplasia. The pathogenesis of HLHS is unknown, but hemodynamic disturbances are assumed to play a prominent role. Methods: To identify perturbations in gene programs controlling ventricular muscle lineage development in HLHS, we performed whole-exome sequencing of 87 HLHS parent–offspring trios, nuclear transcriptomics of cardiomyocytes from ventricles of 4 patients with HLHS and 15 controls at different stages of heart development, single cell RNA sequencing, and 3D modeling in induced pluripotent stem cells from 3 patients with HLHS and 3 controls. Results: Gene set enrichment and protein network analyses of damaging de novo mutations and dysregulated genes from ventricles of patients with HLHS suggested alterations in specific gene programs and cellular processes critical during fetal ventricular cardiogenesis, including cell cycle and cardiomyocyte maturation. Single-cell and 3D modeling with induced pluripotent stem cells demonstrated intrinsic defects in the cell cycle/unfolded protein response/autophagy hub resulting in disrupted differentiation of early cardiac progenitor lineages leading to defective cardiomyocyte subtype differentiation/maturation in HLHS. Premature cell cycle exit of ventricular cardiomyocytes from patients with HLHS prevented normal tissue responses to developmental signals for growth, leading to multinucleation/polyploidy, accumulation of DNA damage, and exacerbated apoptosis, all potential drivers of left ventricular hypoplasia in absence of hemodynamic cues. Conclusions: Our results highlight that despite genetic heterogeneity in HLHS, many mutations converge on sequential cellular processes primarily driving cardiac myogenesis, suggesting novel therapeutic approaches.

1 April 2025 in Circulation
Verified
Journal Article
Closed access
JSJosef Stehlik
Josef Stehlik
MFMaryjane A. Farr
Maryjane A. Farr
MMMandeep Mehra
Mandeep Mehra
JSJacob N. Schroder
Jacob N. Schroder
DDDavid A. D’aLessandro
David A. D’aLessandro
CMCarmelo A. Milano
Carmelo A. Milano
BACKGROUND: A preservation system, the Organ Care System (OCS; TransMedics) uses normothermic pulsatile perfusion during organ transport for heart transplantation. This system has demonstrated favorable outcomes in hearts recovered from extended-criteria donors after brain death (DBD) and donors after circulatory death (DCD). METHODS: The OCS Heart Perfusion Registry collects data on US heart transplantations using the OCS, static cold storage (SCS), or thoracoabdominal normothermic regional perfusion (NRP) and donor hearts recovered from DBD or DCD donors. We analyzed donor and recipient characteristics and posttransplantation outcomes in patients transplanted with OCS donor hearts (either DBD or DCD) compared with SCS hearts, and with OCS hearts from DCD donors compared with those recovered with NRP followed by SCS. Propensity score matching was used in survival analyses to adjust for differences among recipient characteristics. RESULTS: Between 2021 and 2023, 3225 consecutive heart transplantations enrolled from 56 centers were analyzed in the Heart Perfusion Registry. The OCS was used in 854 of 3225 heart transplantations (26.4%), among which 340 (39.8%) were DBD and 514 (60.2%) were DCD donors, whereas 2174 DBD donors were recovered with SCS and another 197 DCD donors with NRP techniques. The OCS-DBD group experienced a greater number of organ offer refusals before final acceptance (13 versus 6; Wilcoxon rank sum, P <0.001) and a longer transport distance (667 miles versus 232 miles; Wilcoxon rank sum, P <0.001) compared with SCS-DBD. Survival at 12 months was similar between the 2 groups (89.9% for OCS-DBD versus 90.6% for SCS-DBD; marginal Cox model, P =0.54). Among the OCS-DCD and SCS-DBD groups, survival at 12 months was also similar (91.0% versus 92.5%, respectively; marginal Cox model, P =0.32). The OCS-DCD and NRP-DCD groups demonstrated similar survival (91.0% versus 91.7%, respectively; log rank, P =0.63), although the transport distance was longer in OCS-DCD compared with DCD with NRP followed by SCS (400 miles versus 223 miles; Wilcoxon rank sum, P <0.001). By 2023, 90% of all OCS donor management and recovery was performed with dedicated organ recovery teams. CONCLUSIONS: We demonstrate that real-world implementation of the OCS for DBD donors (using predominantly a dedicated recovery team) is associated with expanded donor criteria, longer transport distance, and excellent posttransplantation outcomes. In OCS-DCD donors, outcomes parallel those of donors recovered with NRP-DCD and compare favorably with DBD donor organs.

14 April 2021 in Journal of Cardiac Surgery
Verified
Journal Article
Closed access
PDF file
SYSameh Yousef
Sameh Yousef
SSSaket Singh
Saket Singh
AAAbedalrazaq Alkukhun
Abedalrazaq Alkukhun
BABilal Alturkmani
Bilal Alturkmani
MMMakoto Mori
Makoto Mori
PVPrashanth Vallabhajosyula
Prashanth Vallabhajosyula

1 January 2009 in Congenital Heart Disease
Verified
Journal Article
Closed access
PDF file
DTDeepika Thacker
Deepika Thacker
PGPeter J. Gruber
Peter J. Gruber
PWPaul M. Weinberg
Paul M. Weinberg
MCMeryl S. Cohen
Meryl S. Cohen
Heterotaxy syndrome is a term used to describe disorders of lateralization of thoracic and abdominal organs as well as atria. It is commonly associated with complex congenital heart disease as well as abnormalities of the spleen, intestinal malrotation, and abnormalities of liver and stomach position. Most reported cases of heterotaxy syndrome are sporadic, though familial occurrences have also been reported. We report a case of monozygotic twins, both with heterotaxy syndrome, complex congenital heart disease, and anatomical features in both twins that are almost mirror images to each other.

25 January 2022 in JCI Insight
Verified
Journal Article
Open access
PDF file
CTClara Sze-man TANG
Clara Sze-man TANG
MMMimmi Mononen
Mimmi Mononen
WLWai-Yee Lam
Wai-Yee Lam
SJSheng Chih Jin
Sheng Chih Jin
XZXuehan Zhuang
Xuehan Zhuang
PGPeter J. Gruber
Peter J. Gruber
Tetralogy of Fallot (TOF) is the most common cyanotic heart defect, yet the underlying genetic mechanisms remain poorly understood. Here, we performed whole-genome sequencing analysis on 146 nonsyndromic TOF parent-offspring trios of Chinese ethnicity. Comparison of de novo variants and recessive genotypes of this data set with data from a European cohort identified both overlapping and potentially novel gene loci and revealed differential functional enrichment between cohorts. To assess the impact of these mutations on early cardiac development, we integrated single-cell and spatial transcriptomics of early human heart development with our genetic findings. We discovered that the candidate gene expression was enriched in the myogenic progenitors of the cardiac outflow tract. Moreover, subsets of the candidate genes were found in specific gene coexpression modules along the cardiomyocyte differentiation trajectory. These integrative functional analyses help dissect the pathogenesis of TOF, revealing cellular hotspots in early heart development resulting in cardiac malformations.